Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Impact of GLP-1/GIP Agonists on Bowel Preparation Quality
NCT07127354Phase 4Recruiting
- Sponsor
- Cleveland Clinic
- Start
- Aug 2025
- Primary completion
- Aug 2026
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in inadequate bowel preparation (IBP) (2 arms), sponsored by Cleveland Clinic. Primary endpoint: Rate of inadequate bowel preparation. Started Aug 2025; status: recruiting.
02
Conditions
inadequate bowel preparation (IBP)
Beyond the preview
Go deeper on NCT07127354.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07127354.